[go: up one dir, main page]

WO2008108927A3 - Procédés et compositions de stabilisation de polypeptides - Google Patents

Procédés et compositions de stabilisation de polypeptides Download PDF

Info

Publication number
WO2008108927A3
WO2008108927A3 PCT/US2008/002261 US2008002261W WO2008108927A3 WO 2008108927 A3 WO2008108927 A3 WO 2008108927A3 US 2008002261 W US2008002261 W US 2008002261W WO 2008108927 A3 WO2008108927 A3 WO 2008108927A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
stabilizing polypeptides
stabilizing
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/002261
Other languages
English (en)
Other versions
WO2008108927A2 (fr
Inventor
Gabriel Sosne
David Crockford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RegeneRx Biopharmaceuticals Inc
Original Assignee
RegeneRx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RegeneRx Biopharmaceuticals Inc filed Critical RegeneRx Biopharmaceuticals Inc
Publication of WO2008108927A2 publication Critical patent/WO2008108927A2/fr
Publication of WO2008108927A3 publication Critical patent/WO2008108927A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un procédé de stabilisation d'un polypeptide à l'extérieur d'un corps combinant le polypeptide à une solution aqueuse qui inclut des niveaux pratiquement physiologiques d'électrolytes et de sels.
PCT/US2008/002261 2007-03-06 2008-02-21 Procédés et compositions de stabilisation de polypeptides Ceased WO2008108927A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90505107P 2007-03-06 2007-03-06
US60/905,051 2007-03-06

Publications (2)

Publication Number Publication Date
WO2008108927A2 WO2008108927A2 (fr) 2008-09-12
WO2008108927A3 true WO2008108927A3 (fr) 2008-12-04

Family

ID=39738962

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/002261 Ceased WO2008108927A2 (fr) 2007-03-06 2008-02-21 Procédés et compositions de stabilisation de polypeptides

Country Status (1)

Country Link
WO (1) WO2008108927A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
US10406208B2 (en) 2014-10-22 2019-09-10 G-Treebnt Co., Ltd. Composition containing thymosin beta 4, and pharmaceutical formulation comprising same
US9867868B2 (en) * 2015-08-18 2018-01-16 G-Treebnt Co., Ltd. Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid
JP6996713B2 (ja) * 2015-10-06 2022-02-04 エイチエルビー・セラピューティクス・カンパニー・リミテッド チモシンベータ４を含む眼科用製剤の製造方法
KR102115158B1 (ko) * 2016-11-29 2020-05-26 주식회사 지트리파마슈티컬 티모신 베타 4 를 함유하는 제형
KR102340750B1 (ko) * 2017-03-03 2021-12-21 에이치엘비테라퓨틱스 주식회사 티모신 베타 4를 유효성분으로 포함하는 안정화된 외용 제제
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHI E.Y. ET AL.: "Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation", PHARM. RES., vol. 20, no. 9, September 2003 (2003-09-01), pages 1325 - 1336, XP002475010 *
GOLDSTEIN A.L. ET AL.: "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues", TRENDS IN MOLECULAR MEDICINE, vol. 11, no. 9, September 2005 (2005-09-01), pages 421 - 429, XP005065335 *
PHILP D. ET AL.: "Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice in aged mice", WOUND REPAIR AND REGENERATION, vol. 11, no. 1, January 2003 (2003-01-01) - February 2003 (2003-02-01), pages 19 - 24, XP002441696 *
WANG W. ET AL.: "Antibody Structure, Instability, and Formulation", J. PHARM. SCI., vol. 96, no. 1, January 2007 (2007-01-01), pages 1 - 26, XP009084505 *

Also Published As

Publication number Publication date
WO2008108927A2 (fr) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2008108927A3 (fr) Procédés et compositions de stabilisation de polypeptides
NZ600330A (en) Device for hand disinfection
WO2012014074A3 (fr) Compensation de mouvement pour des thérapies de traitement non invasives
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
WO2011143346A3 (fr) Implant avec stabilisants déployables
WO2009020067A1 (fr) Préparation cosmétique liquide
ES3042186T3 (en) Stabilized, sterilized collagen scaffolds with active adjuncts attached
WO2008107568A3 (fr) Procede de preparation de polyhydroxy-urethanes
SMT201500015B (it) Composizione farmaceutica comprendente (1S)-1,5-anidro-1-[5-(4-etossibenzil)-2- metossi-4-metilfenil]-1-tio-d-glucitolo e un secretagogo dell'insulina
NZ597757A (en) Aqueous insulin preparations containing methionine
WO2007083108A3 (fr) Élément allongé implantable
TN2012000248A1 (en) Novel spiropiperidine compounds
WO2010107874A3 (fr) Méthodes permettant d'agir sur la composition du corps au moyen d'agonistes d'amyline
IL221243A0 (en) Heterocyclic inhibitors of glutaminyl cyclase (qc,ec 2.3.2.5)
WO2012095667A3 (fr) Améliorations en technologie de revêtement
GB201117233D0 (en) Stabilisation of polypeptides
WO2011047148A3 (fr) Plénum électrochirurgical
WO2011144335A8 (fr) Préparation de paracétamol injectable stable, prête à l'emploi
WO2009117740A3 (fr) Traitement de la dégénérescence du disque intervertébral
WO2009144551A3 (fr) Utilisation de la dronédarone ou un sel pharmaceutiquement acceptable de celle-ci, pour la préparation d’un médicament permettant la régulation du niveau de potassium dans le sang
WO2008051539A3 (fr) Processus de préparation de sels de palonosetron
WO2011051916A3 (fr) Formulations de protéine stabilisées et utilisation correspondante
EP1832622A3 (fr) Procédé de production de résine à fixant sélectivement l'arsenic
WO2011109418A3 (fr) Appareil pour déploiement de récipient de stockage et son procédé de fabrication
EA201190256A1 (ru) Способ снижения уровня убиквитинилированных белков

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08725854

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08725854

Country of ref document: EP

Kind code of ref document: A2